Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 28, 2016
[A Retrospective Study of Ph Negative Adolescent and Young Adults with Acute B Lymphoblastic Leukemia in Two Centers]Hong-Hao Gao, Yu Jing, Ming-Juan Liu, et al.
International Journal of Hematology|November 19, 2013
Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized studyDai-hong Liu, Lan-ping Xu, Xiao-hui Zhang, et al.
Frontiers in Immunology|May 2, 2025
Updates from a single-center phase 2 study of PD-1 inhibitor combined with hypomethylating agent plus CAG regimen in patients with relapsed/refractory acute myeloid leukemiaHui-Sheng Zhou, Yong-Feng Su, Jun Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 19, 2006
[Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation]Ya-zhen Qin, Jin-lan Li, Hong-hu Zhu, et al.
Chinese Medical Journal|April 12, 2012
Allo-hematopoietic stem cell transplantation is a potential treatment for a patient with a combined disorder of hereditary spherocytosisXiao-hui Zhang, Hai-xia Fu, Lan-ping Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 20, 2006
[Analysis of 66 cases received hematopoietic stem cell transplantation from unrelated donors]Yu-hong Chen, Xiao-jun Huang, Huan Chen, et al.
Clinical Transplantation|September 17, 2011
The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantationMing-Rui Huo, Lan-Ping Xu, D Li, et al.
International Journal of Cancer|August 21, 2014
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groupsXiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Frontiers in Immunology|September 2, 2024
Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemiaYu-Xin Wang, An Wang, Yong-Feng Su, et al.
Journal of Hematology & Oncology|June 12, 2012
Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemiaHuan Chen, Kai-yan Liu, Lan-ping Xu, et al.
Pageof 21